Clinical Trial Update: Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 2 study of ado-trastuzumab emtansine for HER2-amplified or HER2-mutant cancers; the trial is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Lung Cancer
• Urinary Tract Cancer

Drugs mentioned

• ado-trastuzumab emtansine (Kadcyla) (ado-trastuzumab emtansine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Solid Tumor Cancers, Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING